StockGuru Morning Alerts for Monday, November 6, 2006 Featuring The Immune Response Corporation, EnXnet, Rotoblock, Northamerican Energy, ALR Technologies, and GeneThera
The Immune Response Corporation (OTCBB: IMNR) The Immune Response Corporation (OTCBB: IMNR) - Friday’s shares closed down 1.02% to $0.0195. 5,233,056 shares were traded. The Immune Response Corporation announced on Otober 30th that Dr. Joseph O’Neill, President and CEO, will present an overview of the Company’s immune-based therapies, currently in Phase II clinical trials, at the Rodman & Renshaw Eighth Annual Healthcare Conference in New York City. Dr. O’Neill will discuss a key strategic agreement, signed October 10, 2006, with Accelsiors CRO & Consultancy Services, a clinical research organization (CRO) with extensive experience in conducting multiple sclerosis (MS) trials, to…